Marizyme, Inc. Jupiter, Florida 33458Agreement to Transfer Option and Amendatory Agreement • November 2nd, 2022 • Marizyme Inc • Pharmaceutical preparations • Nevada
On July 19, 2019, Marizyme, Inc. (the “Company”) entered into the Stock Option Agreement (the “Stock Option Agreement”) with you (the “Seller”). Under Section 6 of the Stock Option Agreement, the Option (as defined in the Stock Option Agreement) is not transferable by Seller other than to a designated beneficiary upon Seller’s death or by will or the laws of descent and distribution. Seller and the Company desire that Seller sell and transfer the remaining unexercised rights under the Option (the “Sale”) to the Company or its designees for the aggregate consideration of $100,000 (the “Purchase Price”). In order to permit the Sale, the Company is willing to amend the Option to permit its transfer to the Company’s designees solely to facilitate the Sale.
